# Study to Evaluate the Safety and Efficacy of Inhaled PT001 in Patients With Chronic Obstructive Pulmonary Disease (COPD)

> **NCT00871182** · PHASE1,PHASE2 · COMPLETED · sponsor: **Pearl Therapeutics, Inc.** · enrollment: 33 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** Inhaled PT001
- **DRUG:** Inhaled Placebo
- **DRUG:** Tiotropium Handihaler

## Key facts

- **NCT ID:** NCT00871182
- **Lead sponsor:** Pearl Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2009-09
- **Final completion:** 2009-09
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2013-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00871182

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00871182, "Study to Evaluate the Safety and Efficacy of Inhaled PT001 in Patients With Chronic Obstructive Pulmonary Disease (COPD)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00871182. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*